Clinical trial
Influence of Platelet Reactivity in Peripheral Arterial Disease Patients Undergoing Percutaneous Angioplasty on Mid-term Outcomes
NCT04165629 is registered in ClinicalTrials.gov with Clinical Centre of Serbia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Influence of Platelet Reactivity in Peripheral Arterial Disease Patients Undergoing Percutaneous Angioplasty on Mid-term Outcomes
- Lead sponsor
- Clinical Centre of Serbia
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 1, 2020
- Completion date
- July 1, 2022
- Enrollment
- 450 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
claudication, intermittent, critical limb ischemia, peripheral artery disease